Reuters logo
BRIEF-Celgene says net pre-tax charge to Q4 earnings estimated to be $300 mln to $500 mln
October 19, 2017 / 9:38 PM / in 2 months

BRIEF-Celgene says net pre-tax charge to Q4 earnings estimated to be $300 mln to $500 mln

Oct 19 (Reuters) - Celgene Corp:

* Celgene - concluded oct 18 will recognize q4 charge to earnings related to impairment of about $1,600 million ged-0301 IPR&D asset - sec filing

* Celgene - concluded oct 18 will recognize q4 charge to earnings also related to wind-down costs related to discontinuing the trials

* Celgene says net pre-tax charge to q4 earnings estimated to be $300 million to $500 million, or $0.27 to $0.45/share after tax regarding discontinuation of trials Source text - bit.ly/2io1kzN Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below